149 related articles for article (PubMed ID: 34674410)
1. Novel thiazolyl-hydrazone derivatives including piperazine ring: synthesis,
Osmaniye D; Alaşan R; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
Z Naturforsch C J Biosci; 2022 Mar; 77(3-4):167-175. PubMed ID: 34674410
[TBL] [Abstract][Full Text] [Related]
2. MAO enzymes inhibitory activity of new benzimidazole derivatives including hydrazone and propargyl side chains.
Can ÖD; Osmaniye D; Demir Özkay Ü; Sağlık BN; Levent S; Ilgın S; Baysal M; Özkay Y; Kaplancıklı ZA
Eur J Med Chem; 2017 May; 131():92-106. PubMed ID: 28301816
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies.
Evranos-Aksöz B; Yabanoğlu-Çiftçi S; Uçar G; Yelekçi K; Ertan R
Bioorg Med Chem Lett; 2014 Aug; 24(15):3278-84. PubMed ID: 24986657
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of new derivatives containing pyridine, investigation of MAO inhibitory activities and molecular docking studies.
Osmaniye D; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA; Turan G
Z Naturforsch C J Biosci; 2022 Nov; 77(11-12):509-517. PubMed ID: 35858184
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of New Hydrazone Derivatives for MAO Enzymes Inhibitory Activity.
Can NÖ; Osmaniye D; Levent S; Sağlık BN; İnci B; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2017 Aug; 22(8):. PubMed ID: 28825649
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel thiazolyl hydrazone derivatives as potent dual monoamine oxidase-aromatase inhibitors.
Evren AE; Nuha D; Dawbaa S; Sağlık BN; Yurttaş L
Eur J Med Chem; 2022 Feb; 229():114097. PubMed ID: 34998057
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, in vitro, and in silico studies of 1,2,4-triazole-piperazine hybrid derivatives as potential MAO inhibitors.
Uslu H; Osmaniye D; Sağlik BN; Levent S; Özkay Y; Benkli K; Kaplancikli ZA
Bioorg Chem; 2021 Dec; 117():105430. PubMed ID: 34678603
[TBL] [Abstract][Full Text] [Related]
8. Design and Synthesis of New Benzothiazole Compounds as Selective hMAO-B Inhibitors.
Ilgın S; Osmaniye D; Levent S; Sağlık BN; Acar Çevik U; Çavuşoğlu BK; Özkay Y; Kaplancıklı ZA
Molecules; 2017 Dec; 22(12):. PubMed ID: 29232838
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Screening of Human Monoamine Oxidase-A Inhibitor Effect of New 2-Pyrazoline and Hydrazone Derivatives.
Evranos-Aksöz B; Baysal İ; Yabanoğlu-Çiftçi S; Djikic T; Yelekçi K; Uçar G; Ertan R
Arch Pharm (Weinheim); 2015 Oct; 348(10):743-56. PubMed ID: 26293971
[TBL] [Abstract][Full Text] [Related]
10. Novel Thiosemicarbazone Derivatives: In Vitro and In Silico Evaluation as Potential MAO-B Inhibitors.
Osmaniye D; Kurban B; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771054
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO-B dual inhibitors.
Osmaniye D; Evren AE; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100450. PubMed ID: 34931332
[TBL] [Abstract][Full Text] [Related]
12. New Human Monoamine Oxidase A Inhibitors with Potential Anti- Depressant Activity: Design, Synthesis, Biological Screening and Evaluation of Pharmacological Activity.
Evranos-Aksoz B; Ucar G; Tas ST; Aksoz E; Yelekci K; Erikci A; Sara Y; Iskit AB
Comb Chem High Throughput Screen; 2017; 20(6):461-473. PubMed ID: 28474547
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, in vitro, and in silico studies of new derivatives of diphenylpiperazine scaffold: A key substructure for MAO inhibition.
El-Halaby LO; El-Husseiny WM; El-Messery SM; Goda FE
Bioorg Chem; 2024 Feb; 143():107011. PubMed ID: 38061181
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis and Biological Evaluation of Novel N-Pyridyl-Hydrazone Derivatives as Potential Monoamine Oxidase (MAO) Inhibitors.
Turan-Zitouni G; Hussein W; Sağlık BN; Tabbi A; Korkut B
Molecules; 2018 Jan; 23(1):. PubMed ID: 29316677
[TBL] [Abstract][Full Text] [Related]
15. (Thiazol-2-yl)hydrazone derivatives from acetylpyridines as dual inhibitors of MAO and AChE: synthesis, biological evaluation and molecular modeling studies.
D'Ascenzio M; Chimenti P; Gidaro MC; De Monte C; De Vita D; Granese A; Scipione L; Di Santo R; Costa G; Alcaro S; Yáñez M; Carradori S
J Enzyme Inhib Med Chem; 2015 Dec; 30(6):908-19. PubMed ID: 25807300
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, molecular modelling and biological activity of some pyridazinone derivatives as selective human monoamine oxidase-B inhibitors.
Özdemir Z; Alagöz MA; Uslu H; Karakurt A; Erikci A; Ucar G; Uysal M
Pharmacol Rep; 2020 Jun; 72(3):692-704. PubMed ID: 32144745
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of new hydrazone derivatives and evaluation of their monoamine oxidase inhibitory activity.
Tok F; Sağlık BN; Özkay Y; Ilgın S; Kaplancıklı ZA; Koçyiğit-Kaymakçıoğlu B
Bioorg Chem; 2021 Sep; 114():105038. PubMed ID: 34102520
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of oxadiazole clubbed piperazine derivatives as potential antidepressant agents.
Sahu B; Bhatia R; Kaur D; Choudhary D; Rawat R; Sharma S; Kumar B
Bioorg Chem; 2023 Jul; 136():106544. PubMed ID: 37116324
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, monoamine oxidase inhibition and docking studies of new dithiocarbamate derivatives bearing benzylamine moiety.
Kaya Çavuşoğlu B; Sağlık BN; Özkay Y; İnci B; Kaplancıklı ZA
Bioorg Chem; 2018 Feb; 76():177-187. PubMed ID: 29175589
[TBL] [Abstract][Full Text] [Related]
20. Synthesis,
Sağlık BN; Osmaniye D; Acar Çevik U; Levent S; Kaya Çavuşoğlu B; Atlı Eklioğlu Ö; Özkay Y; Koparal AS; Kaplancıklı ZA
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1422-1432. PubMed ID: 32602377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
